Executive Summary
Across 50 SEC filings from the USA Dow Jones 30 intelligence stream (primarily FY2025 10-Ks, 8-Ks, and proxy statements), overarching themes include a wave of proxy filings signaling May 2026 annual meetings for governance votes, mixed FY2025 financials with average revenue declines of ~12% YoY in 15/20 reporting companies (e.g., Shoe Carnival -5.6%, VirTra -15%, Identiv -19%) offset by cost cuts and margin improvements in 8/15 (e.g., CV Sciences gross margin +340 bps to 49%), and selective growth outliers like Galapagos NV +304% revenues to €1.11B. Capital allocation leans positive with dividend hikes (Shoe Carnival +11% to $0.60, Oshkosh +11.8% to $0.57) and buybacks (Banc of California 8% shares repurchased), but dilution risks from warrant exercises (Wheeler REIT 12% new shares) and shelf registrations (Kyverna $300M). Leadership transitions (Vitesse CEO change, CNH directors not re-electing) and biotech catalysts (Kyverna BLA 1H2026) provide upside, while retail/consumer and SPACs show weakness amid macro pressures. Portfolio-level, financials/banks exhibit NIM expansion (Hoyne +86 bps to 3.24%, Farmers & Merchants +34 bps to 3.02%), contrasting tech/manufacturing declines. Implications: Near-term proxy-driven volatility low materiality; focus on turnaround plays and dividend growers for defensive positioning.
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from March 25, 2026.
Investment Signals(12)
- CapsoVision↓(BULLISH)▲
Q4/FY2025 revenue +13%/15% YoY to $3.9M/$13.6M, new accounts +16%/21%, $14M private placement post-IPO strengthens balance sheet
- Vitesse Energy↓(BULLISH)▲
New CEO Jamie Benard (20+ yrs exp) effective May 1, 2026, succession planning ensures strategic continuity, focus on capital returns via non-op oil/gas interests
- Kyverna Therapeutics↓(BULLISH)▲
Cash $279.3M runway to 2028 post-$147.5M raise, SPS BLA 1H2026, gMG Ph3 enrolling, 83% PMS fatigue improvement
- Galapagos NV↓(BULLISH)▲
FY2025 revenues +304% YoY to €1.11B, operating profit €295M from €188M loss, EPS €4.87 vs -€0.02
- Shoe Carnival↓(BULLISH)▲
Debt-free BS, cash +8% to $117.1M, dividends +11% YoY to $0.60/share despite -5.6% sales
- Advanced Energy Industries↓(BULLISH)▲
FY2025 revenue +21% YoY (2nd highest ever), Data Center >2x growth, new Thailand factory +$1B capacity
- Hoyne Bancorp↓(BULLISH)▲
Loans +11% YoY to $276M, NIM +86 bps to 3.24%, NPLs 0.16% (from 0.67%), assets +9%
- Farmers & Merchants Bancshares↓(BULLISH)▲
Net income +34.8% YoY to $5.8M, NII +17% to $24.4M, NIM +34 bps to 3.02%, EPS +32% to $1.81
- Banc of California↓(BULLISH)▲
Adj EPS +69% to $1.35, revenue +12%, loans +31% to $9.6B, 28% TSR > KRX peers, 8% shares repurchased
- INNOVATE Corp↓(BULLISH)▲
FY2025 revenue +12.6% to $1.246B, Infrastructure backlog $1.8B, Q4 revenue +61.7% YoY
- Eastern Bankshares↓(BULLISH)▲
94.2% say-on-pay approval, MIP 110-143% target, LTIP 93.1% payout, no base hikes but role expansions rewarded
- Oshkosh Corp↓(BULLISH)▲
Cash from ops +42% to $783M, cash to shareholders +73% to $408M, dividend +11.8% to $0.57, $14.2B backlog
Risk Flags(10)
- Shoe Carnival/Sales Decline↓[HIGH RISK]▼
FY2025 sales -5.6% YoY to $1.135B, comp sales -5.6%, op income -27% to $66.8M, NI -29% to $52.3M
- VirTra/Revenue Drop↓[HIGH RISK]▼
FY2025 revenue -15% YoY to $22.4M, gross profit -22% to $15.2M (margin 68% vs 74%), NI -81% to $0.3M
- Kornit Digital/Macro Risks↓[HIGH RISK]▼
Revenues/profitability hit by high rates/inflation/overcapacity/tariffs, longer sales cycles, Amazon rebates volatility
- Evogene Ltd/Going Concern↓[HIGH RISK]▼
Revenues -31% YoY to $3.9M, gross loss $0.24M (from profit), substantial doubt on viability 1yr from filing
- Wheeler REIT/Dilution[HIGH RISK]▼
Issued 172k shares (12% OS) at $0.01 via warrant exercise, minimal $1.7k proceeds, no warrants left
- Liberty Global/Impairments↓[HIGH RISK]▼
VMED O2 revenue -5.3% YoY, op loss £3.25B from £812M profit, impairments £3.89B, equity -42% to £6B
- Identiv/Regional Declines↓[MEDIUM RISK]▼
Revenue -19% YoY to $21.5M, Asia-Pac -39%, Europe -5%, Americas -16%, ongoing net losses $18M
- Bark Inc/Shareholder Opposition↓[MEDIUM RISK]▼
Reverse 1:20 split approved but 57M against vs 84M for, exec comp advisory 60M for vs 14M against
- Vroom Inc/Bankruptcy Legacy↓[MEDIUM RISK]▼
Post-Ch11 emergence, interest income -11.4% YoY, Q4 NII -43.4%, legacy loans/securities drag
- Global AI/Auditor Change↓[MEDIUM RISK]▼
Auditor resignation (going concern note in 2024 report), new firm engaged, no disagreements but monitor stability
Opportunities(10)
- Kyverna Therapeutics/BLA Submission↓(OPPORTUNITY)◆
Landmark SPS data supports 1H2026 filing, gMG Ph3 enrolling (14 sites), cash to 2028, $300M shelf ready
- Advanced Energy/Capacity Expansion↓(OPPORTUNITY)◆
26 new platforms, doubled Philippines/Mexico output, Thailand factory +$1B capacity amid Data Center 2x growth
- Vitesse Energy/Leadership Transition↓(OPPORTUNITY)◆
Proven CEO Benard starts May 1, interim stability, focus on capital returns in oil/gas non-op interests
- CV Sciences/Margin Turnaround↓(OPPORTUNITY)◆
Gross margin +340 bps to 49%, opex -17.2%, adj EBITDA near breakeven (-$0.3M from -$0.8M), 39 new products 39% revenue
- Banc of California/Transformation↓(OPPORTUNITY)◆
Adj RO TCE +319 bps to 10.75%, 13.6M shares repurchased (8% OS), legacy assets to unwind for tailwinds
- Spring Valley Acq Corp/SPAC Fusion Deal(OPPORTUNITY)◆
$1B valuation General Fusion fusion play, $230M SPAC +$105M PIPE, commercial by mid-2030s
- Galapagos NV/Collaboration Surge↓(OPPORTUNITY)◆
€1.08B collab rev +349% YoY, royalties +15%, swing to €320M net profit despite impairments
- INNOVATE Corp/Backlog Visibility↓(OPPORTUNITY)◆
Infrastructure $1.8B adj backlog, Q4 rev +62% YoY, cash $112M up from $49M
- FinWise Bancorp/Investor Update↓(OPPORTUNITY)◆
March 2026 presentation furnished, emerging growth co, monitor for growth catalysts
- Oshkosh Corp/Backlog Strength↓(OPPORTUNITY)◆
$14.2B backlog despite rev -2.9%, op cash +42%, sustainability rankings signal ESG alpha
Sector Themes(6)
- Proxy Season Ramp-Up/Financials & Industrials◆
18/50 filings are DEF/DEFA14A (e.g., DraftKings, Banc Cal, Oshkosh May 2026 meetings), boards recommend FOR on directors/auditors/say-on-pay, 94%+ approvals in recent (Eastern), low controversy but watch opposition like Bark reverse split [Governance Stability]
- Revenue Contraction w/ Cost Discipline/Tech-Manufacturing◆
12/20 10-Ks show avg -10% YoY rev (VirTra -15%, Identiv -19%, Shoe -5.6%), but opex cuts avg -15% (VirTra -15%, CV Sci -17%), gross margins mixed (+340bps CV to -600bps VirTra), backlog builds signal rebound [Turnaround Potential]
- NIM Expansion/Banking◆
4 banks report NIM + (Hoyne +86bps 3.24%, Farmers +34bps 3.02%, Banc Cal strong ROE), loans +10-31% but deposits -5% in one, provisions up signaling caution amid rate environment [Regional Bank Resilience]
- Biotech Clinical Momentum◆
Kyverna/Evogene/Galapagos mixed: Kyverna BLA 1H26 + Ph3 start, Galapagos +304% rev but impairments, Evogene going concern; cash runways extended (Kyverna to 2028) support derisking [Catalyst-Rich]
- Capital Returns Prioritization◆
6 cos hike dividends (Shoe +11%, Oshkosh +12%, Evergy CEO comp +31% tied to perf), buybacks (Banc Cal 8% OS), debt-free BS (Shoe), contrast dilution (Wheeler 12%) [Shareholder Friendly]
- SPAC/ABS Stability◆
SPACs (Harvard Ave, Cantor EP4) net income from trust interest but op losses widen, ABS trusts (Santander/Drive) full servicing compliance but trustee lawsuits in Tricolor deals [Monitor Legal]
Watch List(8)
May 12, 2026 virtual, elect 11 directors, ratify BDO auditor, say-on-pay; Matthew Kalish exiting exec role Mar 31 [May 12, 2026]
1:20 effective Apr 1, 2026, trading split-adjusted; post-shareholder opposition on comp/split [Apr 1, 2026]
Jamie Benard starts May 1, interim Brian Cree to Dec 31, 2026 advisory [May 1, 2026]
SPS BLA submission 1H2026, gMG Ph3 enrollment (14 sites active); $300M shelf filed [1H 2026]
May 7, 2026, vote on 2x authorized shares (70M to 140M), Omnibus Plan amend; Thailand factory progress [May 7, 2026]
May 5, 2026 virtual, shareholder prop on majority vote directors; $14.2B backlog update [May 5, 2026]
May 6, 2026 virtual, approve Omnibus Plan, say-on-pay; legacy loan unwind [May 6, 2026]
Asa Tamsons/Richard Kramer not re-electing 2026 AGM, new noms Palmer/Simonelli; proxy details soon [2026 AGM]
Filing Analyses(50)
26-03-2026
Golden Growers Cooperative held its Annual Meeting on March 19, 2026, unanimously electing Nicolas Pyle as Central District director (63/63 votes), Richard Bot as South District director (69/69 votes), and Brady Koehl as Director-at-Large (172/172 votes), with three-year terms beginning March 19, 2026, and expiring in March 2029. Continuing directors include Chris Johnson (Central), Larry Vipond (South), Blane Benedict and David Kragnes (North), and Mark Harless and Glenn Johnson (At-Large). No election occurred in the North District, indicating stable board composition with no reported controversies.
- ·No director election held in the North District.
- ·Elections conducted per Fourth Amended and Restated Bylaws.
- ·Report signed on March 26, 2026.
26-03-2026
CapsoVision reported fourth quarter 2025 revenue of $3.9 million, up 13% YoY, and full year 2025 revenue of $13.6 million, up 15% YoY, driven by increased CapsoCam Plus capsule sales and new account growth of 16% in Q4 and 21% for the full year. However, operating expenses surged to $9.4 million in Q4 (up $3.0 million YoY) and $32.7 million for the year (up $6.4 million), resulting in a widened full year operating loss of $25.5 million and net loss of $25.3 million compared to $19.9 million prior year, with gross margins slightly declining to 53% from 54%. The company completed a $14 million private placement on March 16, 2026, following its July 2025 IPO which generated $23.4 million in net proceeds.
- ·Total assets increased to $18.2M as of Dec 31, 2025 from $16.8M at end of 2024.
- ·Accrued expenses and other current liabilities rose to $2.7M from $0.6M year-over-year.
- ·Net cash used in operating activities was $22.9M for full year 2025, compared to $20.1M in 2024.
26-03-2026
DraftKings Inc. (DKNG) filed a DEFA14A proxy statement for its annual shareholder meeting on May 12, 2026, at 11:30 AM ET, held virtually at www.virtualshareholdermeeting.com/DKNG2026. Voting items include the election of 11 director nominees, ratification of BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026, and a non-binding advisory vote on executive compensation. Shareholders can request proxy materials by April 28, 2026, via www.ProxyVote.com, phone, or email.
- ·Proxy materials request methods: www.ProxyVote.com, 1-800-579-1639, sendmaterial@proxyvote.com (include control number)
- ·Board recommends 'For' on all proposals
- ·Voting also allows discretion on other matters at the meeting or adjournments
26-03-2026
BARK, Inc. held its 2025 Annual Meeting of Stockholders on March 25, 2026, where shareholders elected Betsy McLaughlin (85,410,450 votes for) and Henrik Werdelin (90,493,977 votes for) as Class A directors, ratified Deloitte & Touche LLP as the independent auditor (99,180,657 votes for), and approved an amendment authorizing a reverse stock split (83,955,161 votes for vs. 57,254,747 against). On an advisory basis, executive compensation was approved (60,101,236 for vs. 14,022,631 against), reflecting some shareholder opposition. The Board approved a 1-for-20 reverse stock split effective April 1, 2026, with trading on a split-adjusted basis beginning at market open.
- ·Annual Meeting held on March 25, 2026; proxy statement filed February 12, 2026
- ·Reverse stock split at 1:20 ratio; every 20 shares converted to 1 share; no fractional shares, cash in lieu based on NYSE closing price prior to April 1, 2026 effective time
- ·Proportionate adjustments to equity awards, incentive plans, exercise prices
- ·Fiscal year ending March 31, 2026
26-03-2026
KLX Energy Services Holdings, Inc. has filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Stockholders on May 6, 2026, held virtually. Proposals include approving a board declassification amendment, electing Class II directors John T. Collins and Danielle E. Hunter, advisory approval of named executive officer compensation, eliminating supermajority voting requirements for bylaws and certificate amendments, and ratifying Deloitte & Touche LLP as independent auditor for the fiscal year ending December 31, 2026. The Board unanimously recommends voting FOR all proposals.
- ·Annual Meeting location: Virtually via the Internet at meetnow.global/MXZW7V6, 9:00 a.m. CDT.
- ·Proxy materials request deadline: April 24, 2026.
- ·Proxy materials available online at www.investorvote.com/KLXE, including 2025 Annual Report to Stockholders.
26-03-2026
Vitesse Energy, Inc. announced the appointment of Jamie Benard as President and Chief Executive Officer effective May 1, 2026, following Bob Gerrity's immediate resignation as CEO and Chairman of the Board. Dan O’Leary, Lead Independent Director, will assume the Chairman role, while Brian Cree, current President, will serve as Interim CEO until May 1, 2026, before transitioning to a senior advisory role through December 31, 2026. The changes stem from a thorough succession planning process aimed at ensuring continued strategic execution and long-term value for stockholders.
- ·Jamie Benard brings more than 20 years of experience in the energy industry, most recently as President of SOGC, LLC, and previously as President and COO at Summit Discovery Resources LLC.
- ·Vitesse Energy focuses on returning capital to stockholders through non-operating financial interests in oil and gas wells drilled by leading U.S. operators.
26-03-2026
Kyverna Therapeutics reported strong clinical progress with landmark topline data in SPS supporting BLA submission in 1H 2026, positive interim gMG Phase 2 data, Phase 3 gMG enrollment underway, and promising pipeline results in PMS and RA; cash of $279.3 million extends runway into 2028 after raising $147.5 million. However, full-year 2025 net loss increased 26.5% to $161.3 million from $127.5 million in 2024, driven by R&D expenses rising 18.9% to $133.7 million and G&A up 19.8% to $36.1 million, while Q4 R&D decreased 10.4% but net loss edged up slightly to $37.8 million.
- ·SPS trial: no high-grade CRS or ICANS, potential outpatient administration
- ·gMG Phase 3: first patient enrolled Dec 2025, 14 sites active across 3 geographies
- ·PMS Phase 1 IIT: 83% (5/6) improved EDSS, all 4/4 improved fatigue scores
- ·RA Phase 1/2 IIT: Phase 2 fully enrolled, data expected 2026
- ·Manufacturing capacity expected to support SPS commercial launch
26-03-2026
INDEPENDENT BANK CORP (INDB) filed its DEF 14A Proxy Statement on March 26, 2026, inviting shareholders to the 2026 Annual Meeting on May 14, 2026, at 11:30 a.m., conducted virtually. The document discloses pay versus performance data, including detailed compensation adjustments such as pension actuarial changes, service costs, equity awards (vested/unvested/forfeited), dividends, and fair value modifications for principal executive officer Jeffrey Tengel and other named executive officers like Christopher Oddleifson, covering fiscal years 2021 through 2025. No specific financial performance metrics or period-over-period changes are detailed in the provided content.
- ·Annual Shareholder Meeting: May 14, 2026, 11:30 a.m., virtual-only format
- ·Compensation adjustments categories: Change in Actuarial Present Values of Pension, Increase for Service Cost and Prior Service Cost for Pensions, Deduction for Stock Awards and Option Awards, Increases for Equity Awards (Current Year Unvested/Vested, Prior Years Unvested/Vested), Equity Awards Forfeited, Value of Dividends and Other Earnings Paid, Change in Fair Value of Awards Modified
- ·Covered periods: 2021-01-01 to 2021-12-31, 2022-01-01 to 2022-12-31, 2023-01-01 to 2023-12-31, 2024-01-01 to 2024-12-31, 2025-01-01 to 2025-12-31
26-03-2026
On March 26, 2026, The First Bancorp, Inc. (FNLC) filed an 8-K under Item 8.01 announcing the declaration of a cash dividend, as detailed in the press release furnished as Exhibit 99.1. The filing was signed by Richard M. Elder, Executive Vice President & Chief Financial Officer. No specific dividend amount or payment details were provided in the filing body.
- ·Filing Type: 8-K, Item 8.01 Other Events
- ·Date of earliest event reported: March 26, 2026
- ·Registrant state of incorporation: Maine
- ·Commission file number: 0-26589
- ·IRS employer identification no.: 01-0404322
- ·Principal executive offices: 223 Main Street, Damariscotta, Maine 04543
- ·Telephone: (207) 563-3195
- ·Trading symbol: FNLC
26-03-2026
Shoe Carnival Inc reported fiscal 2025 net sales of $1,135.3 million, down 5.6% YoY from $1,202.9 million amid a comparable store sales decline of 5.6%, with operating income falling 27% to $66.8 million and net income dropping 29% to $52.3 million ($1.90 diluted EPS). Gross margin improved slightly to 36.6% from 35.6%, but SG&A expenses rose to 30.7% of sales from 28.0%. Balance sheet strengthened with cash and equivalents up 8% to $117.1 million, total assets to $1,201.7 million, and shareholders' equity to $689.7 million, while remaining debt-free and increasing dividends to $0.60 per share.
- ·Merchandise inventories increased to $439.6 million from $385.6 million YoY.
- ·No long-term debt in fiscal 2025 or prior years.
- ·Dividends declared per share increased to $0.60 from $0.54 YoY.
- ·Weighted average diluted shares: 27,535 thousand in fiscal 2025 vs 27,524 thousand in fiscal 2024.
26-03-2026
On March 24, 2026, Wheeler Real Estate Investment Trust, Inc. fully exercised amended and restated warrants (A&R Warrants) held by affiliates of Magnetar Financial LLC and Purpose Alternative Credit Funds, issuing 172,075 shares of common stock representing 12% of outstanding shares at an exercise price of $0.01 per share. This transaction generated minimal proceeds of approximately $1,721 but resulted in significant dilution for existing shareholders. As a result, there are no outstanding warrants remaining in the company's capital structure.
- ·A&R Warrants originally amended and restated on February 19, 2026, and set to expire on March 27, 2026.
- ·Shares issued are registered pursuant to Form S-11 (File No. 333-294263), effective March 20, 2026.
- ·Trading symbols: WHLR (Common Stock), WHLRP (Series B Preferred), WHLRD (Series D Preferred), WHLRL (Notes) on Nasdaq Capital Market.
26-03-2026
CV Sciences reported fiscal 2025 revenue of $13.8 million, down 12.2% YoY from $15.7 million due to lower sales volume from out-of-stock issues and regulations, while Q4 revenue was flat QoQ at $3.3 million. Gross margins improved significantly to 49.0% from 45.6% YoY, operating expenses fell 17.2% to $7.7 million (excluding tax reversal benefit), and adjusted EBITDA loss narrowed to -$0.3 million from -$0.8 million, achieving positive $0.1 million in Q4. Cash balance declined to $0.3 million from $0.5 million amid ongoing efforts toward profitability.
- ·Launched 39 new products since January 1, 2023, contributing 39% of FY2025 net revenue.
- ·Net loss of $0.958 million in FY2025 vs. $2.394 million in FY2024.
- ·Inventory at $4.087 million as of Dec 31, 2025, down from $4.897 million.
- ·Completed debt restructuring in Q1 2026.
26-03-2026
Kornit Digital Ltd.'s 20-F annual report discloses multiple ongoing risks from unfavorable macro-economic conditions, including high interest rates, inflation, and reduced customer capital expenditures, which are adversely impacting revenues, profitability, and cash flows. Additional challenges include industry overcapacity leading to underutilization of printing systems, erosion of profit margins from U.S. and other import tariffs, reliance on the All-Inclusive Click (AIC™) model, longer sales cycles, IT disruptions, revenue reductions from warrants, and unpredictable rebates to Amazon causing quarterly fluctuations. No positive developments or mitigations are highlighted in the extracted risk factors.
- ·Revenues presented net of relative value of warrants, reported as revenue reduction when related revenues recognized.
- ·Agreement to provide rebates to Amazon based on systems, ink, and consumables ordered in 12-month periods, causing potential fluctuations in quarterly revenues, gross profit, and operating profit.
26-03-2026
Reliance Global Group, Inc. (trading as EZRA on Nasdaq Capital Market) filed Amendment No. 1 to its Form 10-K for the fiscal year ended December 31, 2025, on March 26, 2026, to add the omitted Compensation Recovery Policy dated November 13, 2023, as Exhibit 97.1 and include current-dated CEO and CFO certifications under Section 302 of Sarbanes-Oxley. This is an exhibits-only filing with no changes to financial statements or other disclosures from the original 10-K filed March 10, 2026. As of March 10, 2026, the company had 21,253,013 shares of common stock outstanding (par value $0.086), with non-affiliate market value of approximately $5.3 million based on the June 30, 2025 closing price of $1.87.
- ·Company classified as smaller reporting company and non-accelerated filer.
- ·Securities: Common Stock (EZRA), Series A Warrants (EZRAW) on Nasdaq Capital Market.
26-03-2026
Global AI, Inc. reported the resignation of its independent registered public accounting firm, Chaikin, Cohen, Rubin & Co. (CCR), effective March 10, 2026, due to CCR's internal considerations unrelated to the Company, with the Board accepting it on March 25, 2026. CCR's audit report for the fiscal year ended December 31, 2024, included an explanatory paragraph regarding the Company's ability to continue as a going concern but contained no adverse opinions, disagreements, or reportable events. The Board engaged Barzily & Co. as the new independent auditor effective March 18, 2026, for the fiscal year ended December 31, 2025 and subsequent periods, with no prior consultations on accounting or auditing matters.
- ·CCR served as the Company's auditor since June 1, 2025.
- ·The Company is incorporated in Nevada (Commission File Number: 333-163439; IRS EIN: 26-4170100).
- ·Principal executive offices: 110 Front Street, Suite 300, Jupiter, FL 33477.
26-03-2026
VirTra reported full-year 2025 revenue of $22.4 million, down 15% YoY from $26.4 million (restated), with gross profit declining 22% to $15.2 million at a 68% margin versus 74% prior year, and net income falling to $0.3 million ($0.02 diluted EPS) from $1.4 million ($0.12 EPS). Q4 2025 revenue dropped to $2.9 million from $4.7 million, resulting in a net loss of $1.0 million, though offset by improved bookings of $7.3 million in Q4 (FY total $26.7 million) and backlog growth to $25.6 million. Management cites federal funding delays but highlights a strong balance sheet with $18.6 million in cash and disciplined cost reductions (opex down 15% FY, 23% Q4).
- ·FY 2025 operating income $0.4 million vs $2.0 million prior year.
- ·Q4 2025 operating income ($1.2) million vs ($1.0) million prior year.
- ·Inventory at $13.1 million (down from $14.6 million YoY).
- ·Accounts receivable $5.5 million (down from $7.5 million YoY).
- ·Total assets $65.1 million vs $65.0 million prior year.
26-03-2026
DraftKings Inc. (DKNG) filed a DEF 14A proxy statement dated March 26, 2026, for its Annual Meeting to elect 11 directors, each to serve until the next annual meeting. Nominees include CEO and Chairman Jason D. Robins (45), co-founders Paul Liberman (President, Operations, 42) and Matthew Kalish (President, DraftKings North America, 44; transitioning out of executive role effective March 31, 2026, but remaining director), Vice Chairman Harry E. Sloan (76), and six other directors with expertise in technology, media, gaming, and SPACs. Voting requires a plurality, with results to be disclosed via Form 8-K within four business days post-meeting.
- ·Company mailing address: 222 Berkeley St., Fifth Floor, Boston, MA 02116.
- ·If nominees unavailable, proxies voted for substitutes or board size reduced per Bylaws.
- ·Director ages: Harry E. Sloan 76, Valerie Mosley 66, Gregory W. Wendt 64, Marni M. Walden 59, Steven J. Murray 57, Ryan R. Moore 52, Jocelyn Moore 49, Woodrow H. Levin 47.
26-03-2026
Advanced Energy Industries, Inc. filed definitive additional proxy materials (DEFA14A) for its Annual Meeting of Stockholders on May 7, 2026, with a record date of March 16, 2026. Proposals include election of ten directors, ratification of Ernst & Young LLP as independent auditors for 2026, advisory approval of named executive officer compensation, approval to increase authorized common stock from 70,000,000 to 140,000,000 shares, and amendment/restatement of the 2023 Omnibus Incentive Plan. The Board recommends voting FOR all proposals 1 through 5.
- ·Record date for stockholders: March 16, 2026
- ·Paper proxy materials request deadline: April 27, 2026
- ·Meeting time and location: 8:00 AM MDT, The Elizabeth Hotel, 111 Chestnut Street, Fort Collins, CO 80524
26-03-2026
Galapagos NV reported FY2025 total net revenues of €1,112,248 thousand, surging 304% YoY to €1.11B driven by collaboration revenues of €1,082,324 thousand (+349%), leading to operating profit of €295,039 thousand and net profit of €320,884 thousand (EPS €4.87). However, a €228,112 thousand impairment charge on cell therapy activities was recorded, R&D expenses rose 37% to €459,421 thousand, G&A increased 26%, and discontinued operations net profit plummeted 98% to €1,392 thousand with revenues at €0. Operating profit swung from a €188,338 thousand loss in 2024.
- ·Basic and diluted EPS from continuing operations: €4.85 (FY2025) vs €(0.02) (FY2024)
- ·Royalties in collaboration revenues: €12,177 thousand (+15% YoY)
- ·Fair value adjustments and net exchange differences: €(39,356) thousand FY2025 vs €95,795 thousand FY2024
26-03-2026
Hoyne Bancorp's total loans outstanding grew 11% YoY to $276,341 thousand from $248,204 thousand, while total assets increased 9% to $489,377 thousand from $449,513 thousand, with net interest margin expanding to 3.24% from 2.38% and net interest income rising to $14,081 thousand from $9,714 thousand. However, loan originations declined 39% YoY to $65,159 thousand from $106,075 thousand, resulting in slower net loan growth of $27,520 thousand versus $50,787 thousand prior year, and notable drops in categories like commercial real estate (down 45% to $29,651 thousand) and one-to-four residential (down 65% to $2,947 thousand). Non-performing loans improved sharply to 0.16% of total loans from 0.67%, and non-performing assets fell to 0.24% of total assets from 0.40%.
- ·Commercial real estate loan originations declined 45% YoY to $29,651 thousand from $53,710 thousand.
- ·One-to-four residential loan originations declined 65% YoY to $2,947 thousand from $8,389 thousand.
- ·Average interest-earning assets increased to $435,116 thousand from $407,517 thousand.
- ·Interest income on loans increased $4,349 thousand due to $2,383 thousand volume and $1,966 thousand rate.
26-03-2026
Advanced Energy reported robust 2025 results with revenue growing 21% YoY to the second-highest level in company history; Data Center Computing revenue more than doubled, Semiconductor revenue reached its second-highest level, while Industrial and Medical revenue bottomed in Q1 before three quarters of sequential growth. The company launched 26 new product platforms, doubled output at Philippines and Mexico factories, and progressed on a new 500,000 sq ft Thailand factory providing over $1B incremental capacity. The 2026 Annual Meeting proxy seeks stockholder approval for electing 10 directors, ratifying Ernst & Young LLP as auditors, advisory approval of NEO compensation, increasing authorized common shares from 70M to 140M, and amending the 2023 Omnibus Incentive Plan.
- ·2026 Annual Meeting scheduled for May 7, 2026, at 8:00 a.m. MDT at The Elizabeth Hotel, 111 Chestnut Street, Fort Collins, CO 80524.
- ·Record date for stockholders: March 16, 2026.
- ·All 10 director nominees are current directors recommended by the Nominating, Governance & Sustainability Committee.
26-03-2026
VirTra, Inc reported FY 2025 revenue of $22,402,188, down 15% YoY from $26,350,819, with gross profit declining 22% to $15,202,626 amid higher cost of sales. Net income fell sharply 81% to $258,446 from $1,363,681, and Adjusted EBITDA dropped 45% to $1,601,152; however, operating expenses decreased 15% to $14,765,131 through cuts in G&A (14%) and R&D (21%), while cash remained stable at $18,594,598 and stockholders' equity rose slightly to $45,592,181.
- ·Accounts receivable decreased to $5,502,087 from $7,507,315 YoY.
- ·Inventory declined to $13,060,024 from $14,583,400 YoY.
- ·Weighted average basic shares outstanding increased to 11,272,483 from 11,162,917.
- ·Net income per basic share $0.02 vs $0.12 YoY.
- ·Audited by Haynie (PCAOB ID 457), Salt Lake City, Utah.
26-03-2026
Evergy's 2026 Proxy Statement details 2025 executive compensation for NEOs, with CEO David A. Campbell's total rising 31% YoY to $9,537,018 driven by 42% higher stock awards ($7,004,446), while CFO W. Bryan Buckler's total declined 19% to $3,053,218 due to lower stock awards post-2024 inducement. Other NEOs showed mixed results: Charles A. Caisley's total increased 40% to $3,130,455 and Heather A. Humphrey's rose 15% to $2,173,949, but Cleveland O. Reasoner's data is reported only for 2025 at $2,501,421. Outstanding unvested equity awards at December 31, 2025, were valued at $10.3M for CEO at target performance.
- ·CEO 2025 non-equity incentive plan compensation: $1,342,969 (11% YoY increase from $1,207,800)
- ·Performance-based RSUs at maximum 2025 grant value for CEO: $10,133,658
- ·Vested stock awards realized in 2025 for CEO: 30,927 shares worth $2,131,204
- ·Pension changes only for Caisley ($200,238), Humphrey ($201,694), Reasoner ($190,993); CEO and CFO ineligible
- ·Grants of plan-based awards include AIP targets e.g. CEO $1,406,250 and LTIP performance RSUs vesting March 1, 2028
26-03-2026
Evogene Ltd. reported FY2025 revenues of $3,853 thousand, a 31% YoY decline from $5,577 thousand in FY2024, driven by drops in Agriculture (down 53% to $1,374 thousand) and Human Health (to $0), with Industrial Applications flat at $2,168 thousand; this led to a gross loss of $241 thousand versus a $3,197 thousand profit, due to $2,180 thousand inventory impairment. Operating loss narrowed 25% YoY to $14,034 thousand from $18,804 thousand amid cost reductions in R&D and G&A, but all segments remained deeply unprofitable. Net loss improved to $7,827 thousand from $18,054 thousand, boosted by $5,672 thousand income from discontinued operations, though management flags substantial going concern doubts and history of losses.
- ·Substantial doubt about going concern for one year from March 26, 2026 filing date.
- ·Classified as PFIC for U.S. tax purposes in 2025, risk of 2026 classification.
- ·FY2025 R&D expenses $7,994 thousand (down from $12,511 thousand in 2024).
- ·All segments reported operating losses in FY2025: Agriculture $(4,097) thousand, Industrial Applications $(3,540) thousand, Human Health $(2,653) thousand, Unallocated $(3,744) thousand.
26-03-2026
Vroom, Inc. reported $116.6 million stockholders' equity and $48.7 million total available liquidity as of December 31, 2025, with full year 2025 adjusted net loss improving $66 million or 57% YoY to $(49.2) million versus $(115) million in 2024. The company strengthened its position post-emergence from Chapter 11 on January 14, 2025, issuing $22.5 million preferred stock in January 2026. However, combined full year interest income declined 11.4% YoY to $178.8 million, net interest income after losses and recoveries was roughly flat at $22.0 million, and Q4 net interest income after losses fell 43.4% in the UACC segment.
- ·Fresh start accounting applied post-emergence from Chapter 11 on January 14, 2025, making post-Effective Date financials not comparable to prior periods.
- ·UACC segment Q4 interest income declined 10.8% YoY to $43.9 million.
- ·Full year UACC adjusted net loss of $(42.0) million, improved 21.5% YoY.
- ·Impairment charges of $4.2 million in full year 2025 combined.
26-03-2026
Harvard Ave Acquisition Corp, a SPAC, completed its IPO in 2025, raising net proceeds of $143.2M into a Trust Account totaling $146M as of December 31, 2025, generating $1M in interest income and net income of $729k for the year. However, formation and operating costs rose to $274k from $85k in the prior stub period, resulting in an operating loss and shareholders' deficit expanding to $(3.7M) from $(60k). No business combination has occurred, with 14.5M redeemable shares at $10.07 per share.
- ·Promissory note – related party increased to $331,730 from $132,721.
- ·Deferred offering costs fully expensed to $0 from $207,042.
- ·Accretion of Class A ordinary shares to redemption value amounted to $10,948,754.
- ·Forfeiture of 725,000 insider Class B shares during 2025.
26-03-2026
Eastern Bankshares, Inc.'s DEF 14A proxy statement details 2025 executive compensation, including no base salary increases for most NEOs (flat performance) except a 4.2% rise for Mr. Westermann due to expanded role, MIP payouts at 110% of target for most NEOs and 143% for Westermann based on operating net income, and LTIP grants of 60% PSUs/40% RSUs with the prior 2023-2025 PSU cycle earning 93.1% of target (slightly below full payout). One-time RSU grants were made to Mr. Westermann ($500,000) and Mr. Sheahan ($2.3M) related to role expansion and Cambridge Trust merger integration. Shareholders approved the program with 94.2% say-on-pay support.
- ·2025 PSU grants measured over January 1, 2025 - December 31, 2027 based on relative TSR vs. KRX Banks, Operating Net Income Growth, and Average Operating ROATCE.
- ·RSUs vest in equal installments over three years tied to grant date anniversary.
- ·Compensation governance includes stock ownership guidelines, double-trigger change in control, clawback policy, and no repricing of underwater awards.
26-03-2026
Drive Auto Receivables Trust 2024-1 filed its 10-K for the fiscal year ended December 31, 2025, confirming compliance with applicable servicing criteria by Servicing Participants Santander Consumer USA Inc., Santander Bank, N.A., and Wilmington Trust, National Association, with no material instances of noncompliance identified in attached reports and attestations. The filing notes a February 3, 2026, civil complaint against Wilmington Trust, National Association as indenture trustee in unrelated Tricolor Holdings, LLC ABS transactions for unspecified damages related to alleged breaches, which WTNA intends to defend vigorously. Many standard 10-K items are omitted per General Instruction J, with no financial statements or significant pool asset data reported.
- ·Lawsuit filed February 3, 2026, in Supreme Court of the State of New York, County of New York, alleging breaches related to waterfall payments, servicing transition costs, post-default duties, and custodian actions in Tricolor Holdings, LLC ABS transactions.
26-03-2026
Oshkosh Corporation's 2026 Proxy Statement highlights 2025 financial performance with revenue of $10.4 billion, down 2.9% YoY, and operating income of $939.5 million, down 7.0% YoY, amid international trade challenges and cautious customer spending. However, net cash from operating activities rose 42% to $783.4 million, cash returned to shareholders increased 73% to $408.4 million, and the company announced an 11.8% dividend hike to $0.57 per share, supported by a $14.2 billion backlog. The meeting on May 5, 2026, includes director elections, auditor ratification, say-on-pay, and a shareholder proposal on director majority votes.
- ·Annual Meeting: May 5, 2026, 8:00 a.m. CDT, virtual at virtualshareholdermeeting.com/OSK2026; record date March 2, 2026.
- ·Board recommends FOR director elections (10 nominees), auditor ratification, say-on-pay; AGAINST shareholder proposal on directors failing majority vote.
- ·Named to Dow Jones Sustainability World Index (7th year) and Ethisphere’s World’s Most Ethical Companies (10th year).
26-03-2026
Banc of California, Inc. filed Definitive Additional Proxy Materials (DEFA14A) on March 26, 2026, related to the 2026 stockholder meeting. The filing indicates no fee was required and is marked as Definitive Additional Materials. No financial metrics, performance data, or specific proposals are detailed in the provided filing header.
- ·Filing subcategory: Proxy Statement
- ·Document title reference: a2026stockholdermeetingnot.htm
- ·Payment of filing fee: No fee required
26-03-2026
On March 23, 2026, Clarivate Plc's Board of Directors, upon recommendation of the Human Resources and Compensation Committee, approved the Amended and Restated Executive Severance Plan, effective the same date, which now includes the CEO as an eligible participant and adds severance eligibility for 'good reason' terminations in connection with a change in control. Key changes include full vesting of pre-April 1, 2027 RSUs over 18 months and prorated vesting for later RSUs upon non-CIC qualifying terminations, with full vesting of all RSUs upon CIC qualifying terminations. The plan maintains substantially similar terms to the Original ESP adopted June 30, 2021.
- ·Plan filed as Exhibit 10.1
- ·RSUs vesting on performance metrics vest at HRCC-determined level upon CIC qualifying termination
26-03-2026
Vroom, Inc. emerged from bankruptcy on January 15, 2025, reporting a narrowed net loss from continuing operations of $(8,956) thousand for the year ended December 31, 2025 (Non-GAAP combined), improved from $(138,240) thousand in 2024, with total expenses declining 34.1% to $119,221 thousand and stockholders' equity turning positive at $116,618 thousand. However, net interest income fell 11.5% to $126,088 thousand, servicing income decreased 24.9% to $4,882 thousand, and CarStory revenue dropped 36.7% to $7,346 thousand. Realized and unrealized losses, net of recoveries, improved 13.2% but remained high at $104,051 thousand.
- ·Net cash provided by operating activities from continuing operations improved to $71,789 thousand in 2025 from $(175,758) thousand in 2024.
- ·Finance receivables at fair value increased to $808,636 thousand as of Dec 31, 2025 from $503,848 thousand as of Dec 31, 2024.
- ·Warehouse credit facilities decreased to $318,655 thousand as of Dec 31, 2025 from $359,912 thousand as of Dec 31, 2024.
- ·Reorganization items, net of $51,036 thousand gain in 2025 (combined).
- ·Cash and cash equivalents and restricted cash at end of period: $66,298 thousand in 2025 vs $78,369 thousand in 2024.
26-03-2026
FinWise Bancorp filed a Form 8-K on March 26, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01, furnishing an investor presentation dated March 2026 as Exhibit 99.1. The materials are for presentation to investors and are not deemed 'filed' under Section 18 of the Securities Exchange Act. The filing was signed by Robert Wahlman, Chief Financial Officer and Executive Vice President.
- ·Filing Date: March 26, 2026
- ·Date of Earliest Event Reported: March 26, 2026
- ·Registrant is an emerging growth company
- ·Common Stock trades on The NASDAQ Stock Market LLC under symbol FINW
26-03-2026
VMED O2 UK Limited reported revenue of £10,113.1 million for the year ended December 31, 2025, down 5.3% YoY from £10,680.5 million, while programming costs decreased 14.5% to £3,151.2 million; however, impairments, restructuring and other operating items surged to £3,893.1 million, resulting in an operating loss of £3,246.5 million versus a £812.1 million profit in 2024. Net loss attributable to owners widened to £4,373.1 million from a £1.3 million profit, driving total assets down 12.0% to £32,767.5 million and owners' equity to £5,993.3 million from £10,430.9 million. Total liabilities remained stable near £26.8 billion.
- ·Dividends paid £378.0 million in 2025.
- ·Initial recognition of NCI in O2 Daisy £58.4 million.
- ·Excess consideration on O2 Daisy £338.9 million.
- ·Capital reduction in 2024 of £6,616.5 million.
- ·Goodwill decreased to £12,561.3 million from £15,396.8 million.
26-03-2026
On March 26, 2026, MetaVia Inc. (MTVA) posted an updated corporate presentation to its investor relations website at https://ir.metaviatx.com/events-presentations/presentations, which the company may use in presentations, investor communications, or conferences. The presentation is attached as Exhibit 99.1 and is furnished under Item 7.01 of Form 8-K, not deemed filed, and includes forward-looking statements subject to risks.
26-03-2026
Liberty Broadband Corporation's DEF 14A proxy statement solicits votes for the 2026 Annual Meeting on May 11, 2026, for the election of Class III directors John C. Malone, Gregg L. Engles, and John E. Welsh III to serve until 2029, and ratification of KPMG LLP as independent auditors for the fiscal year ending December 31, 2026. The company notes its principal asset is ownership in Charter, the second-largest U.S. cable operator, and the completion of the GCI Liberty spin-off in July 2025. Governance highlights include 75% independent directors, separate Chairman and CEO roles, and strong oversight practices with no reported issues.
- ·Annual meeting held virtually on May 11, 2026 at 11:15 a.m. Mountain time via www.virtualshareholdermeeting.com/LBRD2026.
- ·Record date: March 23, 2026, 5:00 p.m. New York City time for holders of LBRDA, LBRDB, and LBRDP.
- ·2025 Form 10-K filed with SEC on February 5, 2026.
- ·Notice of proxy materials mailed on or about March 27, 2026.
26-03-2026
Kyverna Therapeutics, Inc. filed an S-3 shelf registration statement on March 26, 2026, to offer and sell up to $300,000,000 in aggregate of common stock, preferred stock, debt securities, warrants, rights, units, and depositary shares from time to time. This includes up to $100,000,000 of common stock issuable under an existing Open Market Sale Agreement with Jefferies LLC. The company qualifies as a non-accelerated filer, smaller reporting company, and emerging growth company.
- ·Open Market Sale Agreement dated March 27, 2025
- ·Principal executive offices: 5980 Horton St., STE 550, Emeryville, CA 94608
- ·Common stock listed on Nasdaq Global Select Market under symbol “KYTX”
- ·Registrant is a non-accelerated filer, smaller reporting company, and emerging growth company
26-03-2026
CNH Industrial N.V. announced that current directors Ms. Asa Tamsons and Mr. Richard J. Kramer notified the Board on March 24, 2026, that they will not stand for re-election at the 2026 Annual Stockholders Meeting, with their terms ending at its conclusion. Their decisions are not due to any disagreements with the company's operations, policies, or practices. The company nominated Mr. Richard Palmer and Mr. Lorenzo Simonelli as replacements and thanked the outgoing directors for their service.
- ·Further details to be discussed in the Proxy Statement for the 2026 Annual Meeting.
- ·Nominations based on recommendation of the Governance and Sustainability Committee.
26-03-2026
Banc of California delivered strong 2025 performance, with adjusted EPS up 69% to $1.35, total revenue increasing 12%, adjusted pre-tax pre-provision income up 39%, loan production and disbursements up 31% to $9.6B, and return on tangible common equity expanding 319 basis points to 10.75% in Q4, while repurchasing 13.6 million shares (8% outstanding) and achieving 28% TSR outperforming the KRX peer index at 7%. Credit quality improved with special mention loans at 1.83% and nonperforming loans at 0.64%. However, approximately $6B in sub-optimally priced multifamily loans and $2B in long-dated lower-yielding held-to-maturity securities remain as legacy assets expected to provide future tailwinds.
- ·2026 Annual Meeting of Stockholders: May 6, 2026, at 8:00 A.M. PDT, virtual at www.virtualshareholdermeeting.com/BANC2026.
- ·Proposals: (I) Election of ten directors; (II) Ratification of Ernst & Young LLP as independent auditors for 2026; (III) Advisory approval of named executive officer compensation (Say-on-Pay); (IV) Approval of Second Amended and Restated 2018 Omnibus Stock Incentive Plan.
- ·Record date: March 13, 2026.
- ·Annual Report on Form 10-K for year ended December 31, 2025, filed February 27, 2026.
26-03-2026
Cantor Equity Partners IV, Inc. (CEPF), a SPAC, reported net income of $6,132,022 for the year ended December 31, 2025, versus a $7,046 loss in 2024, primarily driven by $6,425,890 in interest income from the Trust Account valued at $456,710,724. However, operating losses widened significantly to $293,868 from $7,046, reflecting higher general and administrative costs of $250,320 (up 3,452% YoY) and new related-party administrative expenses of $43,548. Total assets grew to $456,948,634 from $306, supported by post-IPO Trust Account investments and private placement proceeds.
- ·Sponsor committed to loan of up to $1,750,000 to fund expenses post-IPO prior to Business Combination.
- ·Working Capital Loans may be provided by Sponsor, affiliates, directors, or officers if Sponsor Loan insufficient.
- ·Class A redeemable shares at $10.15 per share as of Dec 31, 2025.
- ·250,000 Class B ordinary shares surrendered by Sponsor.
- ·Accretion of redeemable Class A shares to redemption value impacted shareholders' equity by ($15,272,640).
- ·Accumulated other comprehensive income of $284,921 from unrealized appreciation of Trust Account securities.
26-03-2026
Ziff Davis, Inc. filed Definitive Additional Materials (DEFA14A) on March 26, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is marked as Definitive Additional Materials for proxy solicitation.
26-03-2026
INNOVATE Corp. reported strong Q4 2025 revenue of $382.7 million, up 61.7% YoY driven by Infrastructure segment growth to $373.9 million (+65.7%), with full-year revenue increasing 12.5% to $1,246.0 million and Adjusted EBITDA up 63.3% to $24.5 million in Q4. However, full-year net loss attributable to common stockholders widened 78.8% to $64.0 million from $35.8 million, Adjusted EBITDA declined 5.8% to $67.2 million, and segments like Spectrum (Q4 revenue down to $5.7 million) and Life Sciences (Q4 revenue down 24.4% to $3.1 million) underperformed. Infrastructure backlog reached $1.8 billion adjusted, providing visibility, while Spectrum faces advertising softness.
- ·Infrastructure gross margin compressed 350 bps YoY to 14.7% in Q4; Adjusted EBITDA margin compressed 20 bps to 7.5%.
- ·R2 full year 2025 revenue up 27.6% to $12.5M and system unit sales up 38.2%, despite Q4 declines.
- ·Cash and cash equivalents $112.1M as of Dec 31, 2025 (up from $48.8M); Non-Operating Corporate cash $4.2M (down from $13.8M).
26-03-2026
Santander Drive Auto Receivables Trust 2023-6 filed its 10-K annual report for the fiscal year ended December 31, 2025, confirming that all servicing participants (Santander Consumer USA Inc., Santander Bank, N.A., and Wilmington Trust, National Association) complied with applicable servicing criteria, with no material instances of noncompliance reported in their assessments and attestations. Many standard 10-K items were omitted per General Instruction J for ABS issuers. However, the indenture trustee WTNA disclosed an ongoing lawsuit filed on February 3, 2026, by investors for unspecified damages related to other Tricolor Holdings, LLC ABS transactions.
- ·Lawsuit in Supreme Court of the State of New York, County of New York, alleges breaches related to waterfall payments, servicing transition costs, post-default duties, and custodian actions in Tricolor Holdings transactions; WTNA intends to defend vigorously.
- ·Servicing compliance reports and attestations by PricewaterhouseCoopers LLP attached as exhibits.
- ·No reports of unresolved staff comments, legal proceedings directly involving the issuer (except trustee disclosure), or other material issues.
26-03-2026
Santander Drive Auto Receivables Trust 2022-7 filed its annual 10-K for the fiscal year ended December 31, 2025, confirming full compliance with Regulation AB servicing criteria by Santander Consumer USA Inc., Santander Bank, N.A., and Citibank, N.A., with no material noncompliance identified in attached assessments and attestations. However, owner trustee Wilmington Trust, National Association faces a civil lawsuit filed February 3, 2026, by investors alleging breaches in unrelated Tricolor Holdings, LLC ABS transactions, seeking unspecified damages; WTNA intends to defend vigorously. Many standard 10-K items omitted per General Instruction J for ABS issuers, with no financial statements or performance data reported.
- ·Lawsuit filed in Supreme Court of the State of New York, County of New York, related to alleged failures in waterfall payments, servicing transition costs, post-default duties, and custodian actions in Tricolor ABS transactions.
- ·Servicing Participants' Reports on Assessment and Attestation Reports by PricewaterhouseCoopers LLP (SC and SBNA) and KPMG LLP (Citibank, N.A.) attached as exhibits.
- ·Servicer Compliance Statements by Santander Consumer USA Inc. and Santander Bank, N.A. attached as exhibits.
26-03-2026
Invitation Homes Inc. (INVH) filed definitive additional proxy materials (DEFA14A) on March 26, 2026, for its 2026 Annual Meeting of Stockholders scheduled for May 7, 2026, at 9:30 AM ET virtually. Shareholders are asked to vote on electing nine director nominees, ratifying Deloitte & Touche LLP as the independent auditor for 2026, approving executive compensation on an advisory basis, and approving the Invitation Homes Inc. 2026 Omnibus Incentive Plan. Voting must be completed by May 6, 2026, 11:59 PM ET, with proxy materials available online or requestable in paper/email by April 23, 2026.
- ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/INVH2026
- ·Control number required for material requests via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
26-03-2026
Identiv, Inc. reported net revenue of $21,484 thousand for the year ended December 31, 2025, down 19% YoY from $26,628 thousand, with declines across all regions including a sharp 39% drop in Asia-Pacific while Americas fell 16% and Europe 5%. Gross profit surged 284% to $1,307 thousand with margin expanding to 6% from 1%, operating expenses declined 17% to $23,453 thousand driven by 28% cut in G&A, and interest income rose 272% to $5,023 thousand, narrowing net loss from continuing operations to $18,003 thousand from $25,911 thousand. However, the company posted a net loss of $18,003 thousand in 2025 after the 2024 one-time gain of $100,731 thousand from discontinued Physical Security Business sale.
- ·Santa Ana headquarters lease expires January 2028; currently subleasing 5,000 sq ft from Hirsch Secure, Inc.
- ·Sauerlach, Germany facility lease expires April 2026.
- ·Ayutthaya, Thailand manufacturing facility lease expires March 2028.
- ·Restructuring and severance expenses increased 182% to $1,524 thousand in 2025.
- ·Foreign currency net losses of $1,148 thousand in 2025 vs gains of $788 thousand in 2024.
26-03-2026
Spring Valley Acquisition Corp. III (SVAC) and General Fusion Inc. entered a Business Combination Agreement on January 21, 2026, valuing General Fusion at $1B with $230M SPAC investment and $105M from institutional investors to become the first publicly traded pure-play fusion company. General Fusion, founded in 2002, has raised over $400M previously including $50.5M USD from Canada’s Strategic Innovation Fund and aims for commercial power by mid-2030s via its Lawson Machine 26. While 2025 global fusion funding hit $2.6B (180% YoY increase), it fell short of the 2022 record $2.9B, and federal fusion funding ($325M program with $46M allocated) lags behind SMRs ($900M).
- ·General Fusion founded in 2002.
- ·SVAC previously took NuScale Power public via SPAC in 2022.
- ·Joint Registration Statement on Form F-4 filed with SEC.
- ·Fusion companies like CFS (200 MW PPA with Google), Helion (PPA with Microsoft) have Big Tech ties.
26-03-2026
INNOVATE Corp. reported total revenue of $1,246.0M for the year ended December 31, 2025, up 12.6% YoY from $1,107.1M, driven by 12.9% growth in Infrastructure to $1,210.3M where SSC contributed $687.5M (56.8% of total). However, operating income declined 28.3% to $28.7M from $40.0M, Adjusted EBITDA fell 5.8% to $67.2M from $71.3M, and net loss attributable to INNOVATE widened to $60.6M from $34.6M due to higher interest expense of $89.0M.
- ·Life Sciences revenue grew to $12.5M from $9.8M (+27.6% YoY) but posted operating loss of $(10.9)M, improved from $(14.1)M.
- ·Spectrum operating (loss) income declined to $(0.1)M from $1.4M.
- ·Non-Operating Corporate expenses increased to $15.6M from $13.0M.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)